300765.SZ
300765.SZ
CNE100003K04
CSPC INNOVATION
Loading chart...

Company Profile

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. It also provides technology transfer and technical consulting services of biotechnology. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.

Related stocks

000895.SZ
000895.SZ • China
SHUANGHUI
23.79 CNY
12.33B USD 1Y -3.8%
0322.HK
0322.HK • China
TINGYI
12.37 HKD
8.89B USD 1Y +18.4%
002311.SZ
002311.SZ • China
HAID GROUP
42.83 CNY
10.62B USD 1Y -32%
3288.HK
3288.HK • China
HAITIAN FLAV
27.22 HKD
20.27B USD 1Y -17.1%
5285.KL
5285.KL • Malaysia
SDG
6.03 MYR
10.21B USD 1Y +14.2%
2801.T
2801.T • Japan
KIKKOMAN CORP
1,755 JPY
10.28B USD 1Y +35.1%
603288.SS
603288.SS • China
FOSHAN HAITIAN FLAVOURING AND F
33.67 CNY
29.44B USD 1Y -14.4%
300999.SZ
300999.SZ • China
ARAWANA
25.29 CNY
20.52B USD 1Y -19.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
60.6% p.a.
Max Drawdown (5Y)
-63.1%
Sharpe Ratio (5Y)
0.78
Beta Factor
-0.01
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 61.4 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (65.9%) is noticeably higher than the 5Y average (60.6%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (60.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -63.1% in the extended horizon.
ende